These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31359423)
81. Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial. Kazibwe R; Ahmad MI; Hughes TM; Chen LY; Soliman EZ Am Heart J; 2024 Oct; 276():31-38. PubMed ID: 39067559 [TBL] [Abstract][Full Text] [Related]
83. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936 [TBL] [Abstract][Full Text] [Related]
84. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study. Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997 [TBL] [Abstract][Full Text] [Related]
85. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study. Xiao J; Persson AP; Engström G; Johnson LSB BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943 [TBL] [Abstract][Full Text] [Related]
86. Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia. Fixler JS; Byrne JJ; Mcintire DD; Nelson DB; Gary Cunningham F Pregnancy Hypertens; 2024 Mar; 35():1-5. PubMed ID: 38029452 [TBL] [Abstract][Full Text] [Related]
87. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. Lindholm D; Lindbäck J; Armstrong PW; Budaj A; Cannon CP; Granger CB; Hagström E; Held C; Koenig W; Östlund O; Stewart RAH; Soffer J; White HD; de Winter RJ; Steg PG; Siegbahn A; Kleber ME; Dressel A; Grammer TB; März W; Wallentin L J Am Coll Cardiol; 2017 Aug; 70(7):813-826. PubMed ID: 28797349 [TBL] [Abstract][Full Text] [Related]
88. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations. Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393 [TBL] [Abstract][Full Text] [Related]
89. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. deFilippi CR; de Lemos JA; Tkaczuk AT; Christenson RH; Carnethon MR; Siscovick DS; Gottdiener JS; Seliger SL J Am Coll Cardiol; 2012 Dec; 60(24):2539-47. PubMed ID: 23158528 [TBL] [Abstract][Full Text] [Related]
90. Elevations in High-Sensitive Cardiac Troponin T and N-Terminal Prohormone Brain Natriuretic Peptide Levels in the Serum Can Predict the Development of Anthracycline-Induced Cardiomyopathy. Bisoc A; Ciurescu D; Rădoi M; Tântu MM; Rogozea L; Sweidan AJ; Bota DA Am J Ther; 2020; 27(2):e142-e150. PubMed ID: 30648987 [TBL] [Abstract][Full Text] [Related]
91. NT-proBNP and Cardiac Troponin I, but Not Cardiac Troponin T, Are Associated With 7-Year Changes in Cardiac Structure and Function in Older Adults: The ARIC Study. Myhre PL; Claggett B; Ballantyne CM; Hoogeveen RC; Selvin E; Matsushita K; Kitzman D; Konety S; Mosley T; Shah AM Circulation; 2024 Dec; 150(23):1847-1857. PubMed ID: 39315431 [TBL] [Abstract][Full Text] [Related]
92. Longitudinal changes of cardiac troponin and inflammation reflect progressive myocyte stretch and likelihood for hypertension in a Black male cohort: The SABPA study. Jansen van Vuren E; Malan L; von Känel R; Lammertyn L; Cockeran M; Malan NT Hypertens Res; 2019 May; 42(5):708-716. PubMed ID: 30626934 [TBL] [Abstract][Full Text] [Related]
93. Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Price AH; Weir CJ; Welsh P; McLachlan S; Strachan MWJ; Sattar N; Price JF Atherosclerosis; 2017 Sep; 264():67-73. PubMed ID: 28777936 [TBL] [Abstract][Full Text] [Related]
95. Correlations of arterial stiffness/central hemodynamics with serum cardiac troponin T and natriuretic peptide levels in a middle-aged male worksite cohort. Kimura K; Tomiyama H; Matsumoto C; Odaira M; Shiina K; Nagata M; Yamashina A J Cardiol; 2015 Aug; 66(2):135-42. PubMed ID: 25467920 [TBL] [Abstract][Full Text] [Related]
96. NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study. Myhre PL; Tiainen M; Pettilä V; Vaahersalo J; Hagve TA; Kurola J; Varpula T; Omland T; Røsjø H; Resuscitation; 2016 Jul; 104():12-8. PubMed ID: 27109503 [TBL] [Abstract][Full Text] [Related]
97. Predictive value of the novel risk score BETTER (BiomarkErs and compuTed Tomography scorE on Risk stratification) for patients with unstable angina. Xia Y; Xia Y; Xu K; Ma Y; Pan D; Xu T; Lu L; Li D Herz; 2015 Mar; 40 Suppl 1():43-50. PubMed ID: 25171840 [TBL] [Abstract][Full Text] [Related]
98. The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population. Mirza SS; de Bruijn RF; Koudstaal PJ; van den Meiracker AH; Franco OH; Hofman A; Tiemeier H; Ikram MA J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):356-62. PubMed ID: 25918047 [TBL] [Abstract][Full Text] [Related]
99. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction. Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297 [TBL] [Abstract][Full Text] [Related]